Maximus (MMS) Projected to Post Quarterly Earnings on Thursday

Maximus (NYSE:MMS) is projected to issue its Q2 2025 quarterly earnings data before the market opens on Thursday, May 8th. Analysts expect Maximus to post earnings of $1.37 per share and revenue of $1.29 billion for the quarter. Maximus has set its FY 2025 guidance at 5.900-6.200 EPS.

Maximus (NYSE:MMS) last issued its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. On average, analysts expect Maximus to post $6 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Maximus Price Performance

Maximus stock opened at $66.25 on Tuesday. The firm has a market cap of $3.75 billion, a PE ratio of 14.25 and a beta of 0.61. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. The stock’s fifty day moving average price is $67.64 and its two-hundred day moving average price is $73.41. Maximus has a one year low of $63.77 and a one year high of $93.97.

Maximus Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Saturday, May 31st. Investors of record on Thursday, May 15th will be given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.81%. The ex-dividend date is Thursday, May 15th. Maximus’s payout ratio is currently 25.81%.

Insider Buying and Selling at Maximus

In related news, insider Ilene R. Baylinson sold 14,500 shares of the company’s stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the completion of the transaction, the insider now directly owns 2,512 shares in the company, valued at $171,167.68. This represents a 85.23 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Jan Madsen sold 2,439 shares of the business’s stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the sale, the director now directly owns 18,097 shares in the company, valued at approximately $1,225,347.87. The trade was a 11.88 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.60% of the company’s stock.

Analyst Ratings Changes

Separately, StockNews.com cut shares of Maximus from a “buy” rating to a “hold” rating in a research report on Friday, February 14th.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.